Our January 2026 episode was hosted by Dr. Jose Pereira and Dr. Leonie Herx.
During this episode, they highlight the following 4 articles:
Tate DH, Ferguson DL. Subcutaneous Dexmedetomidine for Refractory Symptoms in aHospice Inpatient Unit. J Pain Symptom Manage. Published online October 28, 2025:S0885-3924(25)00903-0. Doi:10.1016/j.jpainsymman.2025.10.014
Thomas B, Barclay G, Mansfield K, Mullan J, Lo WSA. Dexmedetomidine Versus Midazolamfor End-of-Life Sedation: The DREAMS Non-Blinded Randomized Clinical Trial. J PainSymptom Manage. 2025;70(5):459-469. doi:10.1016/j.jpainsymman.2025.07.027
Nolen A, Selby D, Qureshi F, Mills A. Practices of and Perspectives on Palliative SedationAmong Palliative Care Physicians in Ontario, Canada: A Mixed-Methods Study. PalliativeMedicine Reports. 2024;5(1):94-103. Doi:10.1089/pmr.2023.0081
Arias-Rojas M, Arredondo-Holguín E, Carreño-Moreno S. Efficacy of the “PalliActiveCaregivers” intervention for caregivers of patients with cancer in palliative care. BMCPalliative Care. 2025;24(1):235. doi:10.1186/s12904-025-01885-1
Podden och tillhörande omslagsbild på den här sidan tillhör
Pallium Canada. Innehållet i podden är skapat av Pallium Canada och inte av,
eller tillsammans med, Poddtoppen.